DekaBank Deutsche Girozentrale’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,073
| Closed | -$239K | – | 1416 |
|
|
2022
Q2 | $239K | Hold |
4,073
| – | – | ﹤0.01% | 1157 |
|
|
2022
Q1 | $340K | Buy |
4,073
+373
| +10% | +$55.2K | ﹤0.01% | 1128 |
|
|
2021
Q4 | $786K | Buy |
3,700
+100
| +3% | +$21.7K | ﹤0.01% | 993 |
|
|
2021
Q3 | $975K | Hold |
3,600
| – | – | ﹤0.01% | 906 |
|
|
2021
Q2 | $933K | Hold |
3,600
| – | – | ﹤0.01% | 926 |
|
|
2021
Q1 | $1.05M | Hold |
3,600
| – | – | ﹤0.01% | 891 |
|
|
2020
Q4 | $985K | Sell |
3,600
-180
| -5% | -$46.5K | ﹤0.01% | 872 |
|
|
2020
Q3 | $941K | Buy |
+3,780
| New | +$1.19M | ﹤0.01% | 770 |
|
|
2019
Q4 | – | Sell |
-5,867
| Closed | -$1.59M | – | 1189 |
|
|
2019
Q3 | $1.59M | Sell |
5,867
-4,954
| -46% | -$1.82M | 0.01% | 579 |
|
|
2019
Q2 | $5.66M | Buy |
10,821
+4,425
| +69% | +$2.22M | 0.03% | 401 |
|
|
2019
Q1 | $6.39M | Buy |
6,396
+656
| +11% | +$389K | 0.04% | 381 |
|
|
2018
Q4 | $2.88M | Sell |
5,740
-656
| -10% | -$396K | 0.02% | 472 |
|
|
2018
Q3 | $6.39M | Sell |
6,396
-198
| -3% | -$169K | 0.04% | 385 |
|
|
2018
Q2 | $4.8M | Buy |
6,594
+2,407
| +57% | +$2.78M | 0.03% | 406 |
|
|
2018
Q1 | $6.59M | Buy |
4,187
+560
| +15% | +$721K | 0.05% | 349 |
|
|
2017
Q4 | $1.06M | Hold |
3,627
| – | – | 0.01% | 679 |
|
|
2017
Q3 | $1.06M | Hold |
3,627
| – | – | 0.01% | 688 |
|
|
2017
Q2 | $1.05M | Hold |
3,627
| – | – | 0.01% | 680 |
|
|
2017
Q1 | $1.26M | Buy |
3,627
+2,227
| +159% | +$501K | 0.01% | 572 |
|
|
2016
Q4 | $256K | Buy |
1,400
+107
| +8% | +$21.8K | ﹤0.01% | 792 |
|
|
2016
Q3 | $329K | Hold |
1,293
| – | – | ﹤0.01% | 749 |
|
|
2016
Q2 | $271K | Sell |
1,293
-2,534
| -66% | -$566K | ﹤0.01% | 805 |
|
|
2016
Q1 | $779K | Sell |
3,827
-660
| -15% | -$127K | 0.01% | 588 |
|
|
2015
Q4 | $1.16M | Buy |
4,487
+74
| +2% | +$15.2K | 0.01% | 547 |
|
|
2015
Q3 | $726K | Buy |
4,413
+153
| +4% | +$27.1K | 0.01% | 606 |
|
|
2015
Q2 | $799K | Buy |
4,260
+153
| +4% | +$26.3K | 0.01% | 607 |
|
|
2015
Q1 | $678K | Sell |
4,107
-440
| -10% | -$90.4K | 0.01% | 645 |
|
|
2014
Q4 | $1.05M | Sell |
4,547
-420
| -8% | -$89.8K | 0.01% | 554 |
|
|
2014
Q3 | $899K | Buy |
4,967
+127
| +3% | +$24.3K | 0.01% | 533 |
|
|
2014
Q2 | $931K | Buy |
4,840
+167
| +4% | +$29.5K | 0.01% | 509 |
|
|
2014
Q1 | $850K | Buy |
4,673
+273
| +6% | +$54K | 0.01% | 498 |
|
|
2013
Q4 | $764K | Buy |
4,400
+100
| +2% | +$16.1K | 0.01% | 482 |
|
|
2013
Q3 | $674K | Buy |
+4,300
| New | +$795K | 0.01% | 507 |
|
Other funds holding NKTR
DekaBank Deutsche Girozentrale's NKTR Position: Q3 2022 in Review
DekaBank Deutsche Girozentrale sold out of Nektar Therapeutics (NKTR) in Q3 2022, closing a stake of 4,073 shares — an estimated $239K sold.
DekaBank Deutsche Girozentrale first reported a position in NKTR in Q3 2013 and held it in 33 quarters. The position peaked at $6.59M in Q1 2018. 230 funds tracked by Wall St. Rank hold NKTR as of Q3 2022.
- DekaBank Deutsche Girozentrale reported no remaining Nektar Therapeutics position as of Q3 2022 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 4,073 Nektar Therapeutics shares in Q3 2022, an estimated $239K.
- DekaBank Deutsche Girozentrale first reported a position in Nektar Therapeutics in Q3 2013 and held it in 33 quarters.
- DekaBank Deutsche Girozentrale's Nektar Therapeutics position peaked at $6.59M in Q1 2018.
- 230 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2022.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2022, filed 2 Nov 2022.